EDAP TMS S.A. American Depositary Shares/$FOCL
1D1W1MYTD1Y5YMAX
About EDAP TMS S.A. American Depositary Shares
Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.
- Ticker
- $FOCL
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 289
- Headquarters
- Vaulx-En-Velin, France
- Website
- investor.focalone.com
FOCL Metrics
BasicAdvanced
$191M
-
-$1.04
-0.03
-
Price and volume
Market cap
$191M
Beta
-0.03
52-week high
$6.40
52-week low
$1.75
Average daily volume
164K
Financial strength
Current ratio
1.602
Quick ratio
0.875
Long term debt to equity
-1,179.287
Total debt to equity
-1,292.31
Interest coverage (TTM)
-14.73%
Profitability
EBITDA (TTM)
-23.673
Gross margin (TTM)
44.49%
Net profit margin (TTM)
-49.13%
Operating margin (TTM)
-34.53%
Effective tax rate (TTM)
-1.14%
Revenue per employee (TTM)
$270,000
Management effectiveness
Return on assets (TTM)
-22.43%
Return on equity (TTM)
-265.67%
Valuation
Price to revenue (TTM)
1.961
Price to book
-48.29
Price to tangible book (TTM)
-27.17
Price to free cash flow (TTM)
-8.562
Free cash flow yield (TTM)
-11.68%
Free cash flow per share (TTM)
-0.485
Growth
Revenue change (TTM)
10.16%
Earnings per share change (TTM)
62.12%
3-year revenue growth (CAGR)
6.77%
10-year revenue growth (CAGR)
7.06%
3-year earnings per share growth (CAGR)
23.79%
10-year earnings per share growth (CAGR)
19.96%
FOCL News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.